Marco Ruella, MD, received the AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research in 2015. Dr. Ruella shared how an AACR Fellowship helped lay the foundation for dual CAR T-cell therapy.
Raymond E. Moellering, PhD, a recipient of the 2008 AACR Centennial Predoctoral Fellowship in Cancer Research, shared how the grant given to him by the AACR as a doctoral candidate encouraged him to work at the interface of chemistry, biology, and cancer.
Yuanyuan Fu, PhD, discussed the impact of receiving the 2022 AACR-Merck Cancer Disparities Fellowship on her career and research on colorectal cancer disparities in Native Hawaiians/Pacific Islanders.
W. Kimryn Rathmell, MD, PhD, formerly of Vanderbilt University Medical Center and now director of the National Cancer Institute, shares the impact on her career and her research of two AACR-supported research grants that she received during her academic career.
As we continue our celebration of 30 years of impact of the AACR Research Grants Program, we share how recipient of a 2022 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in partnership with Pelotonia and the AACR, Chemtai Mungo, MD, MPH is seeking to make a difference in the lives of women from low and middle-income countries.
As we continue our celebration of 30 years of impact of the AACR Research Grants Program, we feature recipient of the 2022 Award for Outstanding Achievement in Basic Cancer Research, Dr. Christina Curtis. Dr. Curtis shares the impact of her AACR Triple-Negative Breast Cancer (TNBC) Foundation / Carol’s Crusade for a Cure Foundation Career Development Award on her research.
A career development award from the AACR enabled Eddy Yang, MD, PhD, to investigate combinations of targeted treatments in triple negative breast cancer. Now the chair of radiation medicine at the University of Kentucky College of Medicine, Dr. Yang shares how the grant came at a pivotal time in his career.
AACR grant recipient June M. Chan, ScD, has studied how diet and exercise, among other factors, contribute to progression in prostate cancer.
Sara G.M. Piccirillo, PhD, was inspired to study glioblastoma whilst an undergraduate student at the National Carlo Besta Neurological Institute in her hometown of Milan, Italy. Now an assistant professor at the University of New Mexico Health Sciences Center, Dr. Piccirillo, was awarded the AACR-Novocure Tumor Treating Fields (TTFields) Research Grant in 2021 to investigate the impact of TTFields on residual glioblastoma disease.
A fellowship from the AACR enabled Jeffrey Engelman, MD, PhD, to stay in the lab and make the discoveries that launched a successful career that has spanned academic medicine, a pharmaceutical company, and a biotech startup.